Detalhe da pesquisa
1.
Loss of Dnmt3a increased self-renewal and resistance to pegIFNα in JAK2-V617F-positive myeloproliferative neoplasms.
Blood
; 2024 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38493481
2.
Single-cell lineage tracing unveils a role for TCF15 in haematopoiesis.
Nature
; 583(7817): 585-589, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32669716
3.
Iron is a modifier of the phenotypes of JAK2-mutant myeloproliferative neoplasms.
Blood
; 141(17): 2127-2140, 2023 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36758212
4.
The glutaminase inhibitor CB-839 targets metabolic dependencies of JAK2-mutant hematopoiesis in MPN.
Blood Adv
; 8(9): 2312-2325, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38295283
5.
IL-1ß promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells.
Blood Adv
; 8(5): 1234-1249, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38207211